Profile

Denise Angelique Levitan, M.D.

Denise Angelique Levitan, M.D.

Assistant Professor, Hematology & Oncology
Contact Information
Appointment:
336-713-5440
Office:
336-716-4464
Fax:
336-716-5687
Clinical Specialties
Hematologic Malignancies, Lymphomas
Education & Training
  BAUniversity of Chicago1993
  MDUniversity of Chicago1998
ResidencyGeorgetown U Hosp2001
InternshipGeorgetown U Hosp1999
FellowshipUniversity of Chicago Pritzker School of Medicine2004
NPI Number
1871572784
Denise Angelique Levitan, M.D.

Denise Angelique Levitan, M.D.

Assistant Professor, Hematology & Oncology
Contact Information
Appointment:
336-713-5440
Office:
336-716-4464
Fax:
336-716-5687
Recent Publications
Naik S, D'Agostino R Jr, Lamar Z, Graham RM, Vatca M, Agnew E, Higgins A, Levitan D, Hurd D. Outcomes of second transplants for disease recurrence or for myelodysplasia (MDS) developing after an initial transplant (Tx) [abstract]. Biol Blood Marrow Transplant. 2012; 18(2 Suppl 2):S340-S341.

McQuellon R, Duckworth K, Campbell C, Russell G, Naik S, Levitan D, Zamkoff K, McQuellon BT, Hurd D. Fear of recurrence following hematopoetic stem cell transplantation [abstract]. Psychooncology. 2012; 21(Suppl 1):127.

Loth K, Naik S, Kennedy LA, Levitan D, Zamkoff K, Hurd D. Infectious complications associated with the use of antithymocyte globulin in reduced intensity allogeneic transplants [abstract]. Biol Blood Marrow Transplant. 2011; 17(2 Suppl 2):S355-S356.

Naik S, Shope D, Albright C, Graham R, Levitan D, Zamkoff K, D'Agostino R Jr, Hurd D. Transplant outcomes in multiple myeloma patients younger versus older than 60 years of age in the era of newer targeted agents [abstract]. Biol Blood Marrow Transplant. 2011; 17(2 Suppl 2):S252-S253.

Campbell C, McQuellon R, Duckworth K, Russell G, Hurd D, Levitan D, Naik S, Zamkoff K, McQuellon B, Sommer J. Health related quality of life, depressive symptoms and distress before and after hematopoietic cell transplantation [abstract]. Psychooncology. 2011; 20(Suppl 1):81.

Klepin HD, Geiger AM, Tooze JA, Kritchevsky SB, Williamson JD, Ellis LR, Levitan D, Pardee TS, Isom S, Powell BL. The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia. J Am Geriatr Soc. 2011; 59(10):1837-1846.

Pardee T, DeFord-Watts LM, Peronto E, Levitan DA, Hurd DD, Kridel S. Altered lipid and mitochondrial metabolism are viable targets in acute leukemia [abstract]. Blood. 2011; 118(21):1546.

Keung YK, Levitan D, Zamkoff K, Hurd D. Should the concern of myelodysplastic syndrome affect the decision of auto-SCT in lymphoma? [letter]. Bone Marrow Transplant. 2010; 45(2):407-408.


Ritter EM, Zamkoff KW, Levitan DA, Hurd DD. The importance of timing of hematopoietic stem cell transplantation (HSCT) in patients with T-cell lymphomas (T-NHL) [abstract]. Biol Blood Marrow Transplant. 2010; 16(2 Suppl 2):S238.

Kannangara AP, Levitan D, Fleischer AB Jr. Six patients with early-stage cutaneous T-cell lymphoma successfully treated with topical 5-fluorouracil. J Drugs Dermatol. 2010; 9(8):1017-1018.

Klepin HD, Tooze JA, Geiger AM, Kritchevsky S, Williamson J, Ellis LR, Levitan D, Pardee T, Isom S, Powell BL. Geriatric assessment predicts overall survival among older adults receiving induction chemotherapy for acute myelogenous leukemia [abstract]. Blood. 2010; 116(21):653-654.

McCarthy PL, Owzar K, Anderson KC, Hofmeister CC, Hurd DD, Hassoun H, Giralt S, Stadtmauer EA, Richardson PG, Levitan D, et al. Phase III intergroup study of lenalidomide versus placebo maintenance therapy following single autologous hematopoietic stem cell transplantation (AHSCT) for multiple myeloma CALGB 100104 [abstract]. Blood. 2010; 116(21):21-22.

Klepin HD, Ellis LR, Levitan D, Powell BL. Feasibility of inpatient geriatric assessment for older adults with acute myelogenous leukemia [abstract]. J Am Geriatr Soc. 2009; 57(Suppl 1):S155.


Klepin HD, Geiger AM, Williamson J, Kritchevsky S, Tooze JA, Ellis LR, Levitan D, Isom S, Powell BL. Inpatient geriatric assessment detects impairment among older adults receiving induction chemotherapy for acute myelogenous leukemia [abstract]. Blood. 2009; 114(22):570-571.

Keung Y, Beaty MW, Pettenati M, Levitan D, Molnar I, Thakuri M, Cruz J, Hurd DD. Possible role of engraftment syndrome in myelodysplastic syndrome after autologous transplants [abstract]. J Clin Oncol. 2008; 26(Suppl):a18016.

Powell B, D'Agostino R Jr, Levitan D, Ellis LR, Lyerly S, Skiles M, Manuel M, Harrelson R, Kimbrough C, Hurd DD. High dose cytarabine and clofarabine (HiDAC-->CLOF) in relapsed or refractory acute myeloid leukemia, a phase 2 trial [abstract]. Blood. 2008; 112(11):676.

Keung YK, Beaty MW, Pettenati M, Levitan D, Molnar I, Thakuri MC, Cruz J, Hurd DD. Possible role of engraftment syndrome in myelodysplastic syndrome after autologous transplants [abstract]. Blood. 2008; 112(11):751.

Powell BL, Lovato J, Kimbrough C, Lyerly S, Galloway-Daniels S, Harrelson R, Keung YK, Thakuri MC, Molnar I, Levitan D, Hurd DD, et al. Limited phase I trial of sequential high dose cytarabine and clofarabine (HiDAC-->CLOF) in relasped or refractory acute myeloid leukemia [abstract]. Blood. 2006; 108(11 Pt 2):221b.
All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Last Updated 4/30/2012
Quick Reference
Request an Appointment
New Patients
336-716-WAKE
888-716-WAKE
Existing patients may contact the clinic directly.
Find a Doctor

e.g., "allergy," "diabetes"

US News Best Hospital AwardANCC Magnet Association AwardBest Doctors 2011-2012 AwardConsumer Choice #1 Award 2011-2102US News Best Medical Schools 2011 Award

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.